COVID-19 UPDATE: Firm Operations Continue Uninterrupted. Free Virtual Consultations Available. Click Here.
ACCIDENT NEWS

2 Killed in Crash on Interstate 5 Near Route 163


Head-on Crash in San Diego Leads to Fatality

Auto Head On Collision
Auto Head On Collision

San Diego, CA (March 11, 2020) – Two people were killed in a wrong-way crash in San Diego. The fatal accident occurred on the morning of March 11 on Interstate 5.

A sedan was traveling south in the northbound lanes of Interstate 5, near Route 163. The wrong-way driver then hit another sedan head-on. Both drivers, a man and a woman, died at the accident scene.

Our heartfelt condolences go out to the friends and loved ones of the victims.

#San Diego

#92101


July 15, 2020

Pedestrian Killed in Crash on 110 Freeway Near 3rd Street

Man Hit by Vehicle in Fatal Los Angeles Accident...


August 21, 2020

2 Injured in Crash on Dolan Road

2 Vehicles Collide in Moss Landing Accident...


May 27, 2020

Man Killed in Crash on Interstate 5 Near Deschutes Road

Truck Driver Hit by Passing Motorist in Fatal Anderson Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


September 22, 2020

Governor Newsom Signs Bills To Protect Workers During Pandemic

Governor Gavin Newsom signed two bills on Thursday intended to protect California workers during the COVID-19 pandemic, AB 685 and SB 1159.


September 21, 2020

Lawsuit: ‘Tens Of Thousands’ Of Elmiron Patients At Risk For Vision Loss

A lawsuit filed on September 8 claims that “tens of thousands” of Elmiron patients were put at risk and hurt as a result of Janssen Pharmaceuticals’ conduct.